|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00557 TIANYUAN HEALTH
Nominal 
0.890 0.000 (0.000%) | 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | 8,436 | -43.234% | 26,845 | 45,230 | 54,216 | 94,588 |
| Cost of Sales | (303) | -93.944% | (5,607) | (17,285) | (19,391) | (23,281) |
| Gross Profit | 8,133 | -17.498% | 21,238 | 27,945 | 34,825 | 71,307 |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (23,473) | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | 2,497 | (10,013) | (800) | 1,299 | |
| Share of Results of Asso. & JCEs | (106) | 360.870% | (14) | (365) | 242 | 184 | |
| Profit / (Loss) before Taxation | (5,538) | -38.350% | (38,429) | (28,778) | (40,349) | (19,063) | |
| Taxation | 0 | -- | (177) | 1,821 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 2,473 | -26.769% | 4,368 | 11,473 | 11,313 | 2,209 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (3,065) | -45.326% | (34,238) | (15,484) | (29,036) | (16,854) | |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | (6,975) | -1.399% | 2,479 | 3,391 | 3,931 | 4,480 |
| Depreciation & Amortisation | 4,447 | 6.489% | 7,979 | 9,076 | 9,529 | 11,869 |
| Directors' Emoluments | -- | -- | 1,049 | 1,094 | 5,639 | 9,012 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -0.770 | -45.000% | -8.580 | -3.880 | -7.280 | -4.220 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.027 | 0.013 | (0.076) | 0.041 |
| NBV per share ($) | 0.486 | -- | 0.488 | 0.577 | 0.562 | 0.642 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -3,065 |
| %Change | -45.326% |
| EPS / (LPS) | HKD -0.008 |
| NBV Per Share ($) | HKD 0.486 |